Deep Brain Stimulation of the Pallidum is Effective and Might Stabilize Striatal D2 Receptor Binding in Myoclonus–Dystonia
Open Access
- 1 January 2012
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 3, 15796
Abstract
Purpose: To assess clinical efficacy of deep brain stimulation (DBS) of the pallidum in Myoclonus–Dystonia (M–D) patients, and to compare pre- and post-operative striatal dopamine D2 receptor availability. Methods: Clinical parameters were scored using validated rating scales for myoclonus and dystonia. Dopamine D2 receptor binding of three patients was studied before surgery and approximately 2 years post-operatively using 123-I-iodobenzamide Single Photon Emission Computed Tomography. Two patients who did not undergo surgery served as controls. Results: Clinically, the three M–D patients improved 83, 17, and 100%, respectively on the myoclonus rating scale and 78, 23, and 65% on the dystonia rating scale after DBS. Dopamine D2 receptor binding did not change after surgery. In the two control subjects, binding has lowered further. Conclusion: These findings confirm that DBS of the pallidum has beneficial effects on motor symptoms in M–D and suggest this procedure might stabilize dopamine D2 receptor binding.Keywords
This publication has 24 references indexed in Scilit:
- Bilateral Deep Brain Stimulation of the Pallidum for Myoclonus-Dystonia Due to ε-Sarcoglycan MutationsArchives of Neurology, 2011
- Pallidal and thalamic deep brain stimulation in myoclonus‐dystoniaMovement Disorders, 2010
- Reduced striatal D2 receptor binding in myoclonus–dystoniaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Local field potentials and oscillatory activity of the internal globus pallidus in myoclonus–dystoniaMovement Disorders, 2007
- Deep brain stimulation in myoclonus–dystonia syndromeMovement Disorders, 2004
- Inherited myoclonus-dystonia.2004
- Stimulation of the Subthalamic Nucleus in Parkinson's Disease Does Not Produce Striatal Dopamine ReleaseNeurosurgery, 2003
- The Unified Myoclonus Rating Scale.2002
- Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Validity and reliability of a rating scale for the primary torsion dystoniasNeurology, 1985